Have You Ever Thought About the People Behind Your Lab Results? Now’s the Time! April 27, 2023 In honor of Medical Laboratory Professionals Week, taking place April 23 to April 29 this year, we are celebrating our teammates responsible for every clinical... Continue Reading
The Future of Genetic Testing: How a Love of DNA Led to More Comprehensive Tests April 23, 2022 For more than 30 years now, scientists at Myriad Genetics have been finding creative ways to coax new information out of human genes. The love for exploring th... Continue Reading
Inside One of the World’s Most Innovative Companies March 8, 2022 In March 2022, Myriad Genetics was named one of the World’s Most Innovative Companies by Fast Company. Since 2008, Fast Company’s Most Innovative Comp... Continue Reading
Myriad Corporate Statement June 9, 2020 We are heartbroken over the systemic discrimination and racism that have persisted in this nation for too long. We have been quiet in reflection but believe tha... Continue Reading
BRACAnalysis CDx Approved by FDA for Patients with HER2- Metastatic Breast Cancer January 23, 2018 The U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic to identify patients with HER2- metastatic breas... Continue Reading
GeneSight: A personalized approach to help patients get their lives back May 2, 2017 What is GeneSight? [caption id="attachment_14843" align="alignright" width="400"] GeneSight Psychotropic[/caption] GeneSight Psychotropic is a laboratory devel... Continue Reading
Nurturing the Future of Molecular Diagnostics September 29, 2014 Our legacy is that of one of the first genomic companies in history. We pioneered the first commercial molecular diagnostic test for hereditary breast and ovari... Continue Reading
A Mother Gives Thanks for Hereditary Cancer Testing November 18, 2013 After working at Myriad Genetics for more than 20 years, I have been fortunate to see many examples of how our employees’ efforts have truly improved the live... Continue Reading